Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

b-AP15 (NSC687852), Deubiquitinases Inhibitor

b-AP15 (NSC687852), Deubiquitinases Inhibitor

$89.00
A potent and selective deubiquitinases inhibitor for 19S proteasomes activity of Ub-AMC cleavage.
Catalog No. Unit Price Qty

Details

Product Information
Molecular Weight: 419.39
Formula: C22H17N3O6
Purity: ≥98%
CAS#: 67200-34-4
Solubility: DMSO up to 100 mM
Chemical Name: (3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

b-AP15 (NSC686852) is a potent and selective deubiquitinases inhibitor for 19S proteasomes activity of Ub-AMC cleavage with IC50 of 2.1 μM. It inhibits the activity of two 19S regulatory-particle-associated deubiquitinases, UCHL5 and USP14, resulting in accumulation of polyubiquitin. It has minimal inhibition of UCHL-1, UCHL-3, USP2, USP7, USP, BAP1 and proteasome activity. b-AP15 induces apoptosis by cathepsin D-dependent caspase-cleavage (IC50 ~0.5 μM) and displays antitumor activity in vivo.

How to Use:

In vitro: b-AP15 was used at 10 µM final concentration in various in vitro assays.
In vivo: b-AP15 was dosed to mice with HCT-116 colon carcinoma xenografts by intraperitoneal injection at 5 mg/Kg. formulation is Cremophor EL and polyethylene glycol 400 (1:1).

Reference:

  • 1. Berndtsson M, et al. Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system. (2009) Int J Cancer. 124(6):1463-9. 
  • 2. D'Arcy P, et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. (2011) Nat Med. 17(12):1636-40.



b-AP15_spec.pdf      
b-AP15_MSDS.pdf      

Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 419.39
Formula: C22H17N3O6
Purity: ≥98%
CAS#: 67200-34-4
Solubility: DMSO up to 100 mM
Chemical Name: (3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

b-AP15 (NSC686852) is a potent and selective deubiquitinases inhibitor for 19S proteasomes activity of Ub-AMC cleavage with IC50 of 2.1 μM. It inhibits the activity of two 19S regulatory-particle-associated deubiquitinases, UCHL5 and USP14, resulting in accumulation of polyubiquitin. It has minimal inhibition of UCHL-1, UCHL-3, USP2, USP7, USP, BAP1 and proteasome activity. b-AP15 induces apoptosis by cathepsin D-dependent caspase-cleavage (IC50 ~0.5 μM) and displays antitumor activity in vivo.

How to Use:

In vitro: b-AP15 was used at 10 µM final concentration in various in vitro assays.
In vivo: b-AP15 was dosed to mice with HCT-116 colon carcinoma xenografts by intraperitoneal injection at 5 mg/Kg. formulation is Cremophor EL and polyethylene glycol 400 (1:1).

Reference:

  • 1. Berndtsson M, et al. Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system. (2009) Int J Cancer. 124(6):1463-9. 
  • 2. D'Arcy P, et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. (2011) Nat Med. 17(12):1636-40.



b-AP15_spec.pdf      
b-AP15_MSDS.pdf      

Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: